United States · FDA National Drug Code directory
Haloperidol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10135-757_23e5e8d5-bddd-f9a9-e063-6394a90adb0c
- Product NDC
- 10135-757
- Form
- TABLET
- Composition / generic term
- Haloperidol
- Labeler
- Marlex Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220801
- Source listing expiry
- 20261231
Source-listed ingredients
- HALOPERIDOL — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (10135-757-01) · 10135-757-01
- 1000 TABLET in 1 BOTTLE (10135-757-10) · 10135-757-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →